AI-powered solution for personalized treatment of heart failure patients

FHS
June 23, 2023
11:36 pm

Heart failure is the leading cause of hospitalisation in those over 65 and research predicts that the condition will increase in global prevalence by almost 50% by 2030.

ODM-212 by Orion for Solid Tumor: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 28, 2023

Enhertu Gets Tumor-Agnostic FDA Approval for HER2-Positive Cancers

The FDA granted tumor-agnostic accelerated approval to trastuzumab deruxtecan (Enhertu) for previously treated unresectable or metastatic HER2-positive (immunohistochemistry [IHC] 3+) solid cancers. The action represents

April 6, 2024

Q&A: NIAID’s Jeanne Marrazzo speaks on bird flu, mpox, and succeeding Anthony Fauci

A year ago last week, Jeanne Marrazzo stepped into a very big pair of shoes. Marrazzo became the first new director of the National Institute

October 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.